product Image
[SUG] Solg™ E. coli Uracil-DNA Glycosylase (Pre-made Enzyme)
Model Name
-
Series
Research Reagents (Biochemical Regent)
Data
메뉴얼-솔젠트-SUG21-R10h_SolGent™_Uracil-DNA_Glycosylase
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125203
Product Name
[SUG] Solg™ E. coli Uracil-DNA Glycosylase (Pre-made Enzyme)
Model Name
-
Size
-
Weight
-
Product Details

[SUG] Solg™ E. coli Uracil-DNA Glycosylase

Removing DNA contamination in the air which could increase false-positive amplification


Solg™ E.coli Uracil-DNA Glycosylase(UDG) hydrolyzed the N-glycosylic bond between the Uracil base and sugar back bone. SolGent™ Uracil-DNA Glycosylase helps to get accurate diagnosis by removing of crossover or carry over DNA contamination which could increase false-positive amplification. In PCR using UDG system, it is used dUTP instead of dTTP. Please note that it can’t be used together with DNA Polymerase with proofreading function and dUTPase.




Specification

SourceE. coli (K-12 strain)
(Recombinant)
Reaction temp. & time50 ℃ for 3 min
Inactivation95 ℃ for 5 min



Application

Removing of uracil-containing DNA , Elimination carry-over contamination in PCR, PCR diagnosis, Site-directed mutagenesis





Citation&Papers

Choi JJ, Kim CH,

et al., Peptide Nucleic Acid-Based Array for Detecting and Genotyping Human Papillomaviruses, Journal of Clinical Microbiology, 47 : 1785-1790, 2009





Format

Product ImageContentsStorage & Expiry Date

E. coli Uracil-DNA Glycosylase (1 U/㎕)2 years 3 months (In case of Store at -20 ℃ ± 5 ℃)





Ordering information

Cat. No.ProductSizePrice(won)
SUG21-R10hSolGent™ E. coli Uracil-DNA Glycosylase1,000 U
(1,000 reaction)
-




More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry